Feb 4 (Reuters) - Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development. The ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

In a stock market currently obsessed with interest rate cuts and the artificial intelligence (AI) boom, it is easy to overlook the biotechnology sector. However, for investors willing to look beyond ...

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Guggenheim Emerging Outlook: ...

Find the latest biotech news, including an appointment strengthening the pathway from translational research to new company ...

The National Academies of Sciences, Engineering, and Medicine has announced the inaugural cohort of 10 fellows in its new Biotechnology Regulatory Fellowship Program, launched in 2025 to engage ...

A clinical-trial provider sued psychedelic therapy developer Definium Therapeutics on Monday in Delaware federal court, ...

LMU biologists decipher the ionome of chloroplasts and create the foundations for new biotech strategies.

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

April M. Kloxin, professor of chemical and biomolecular engineering and materials science and engineering at the University of Delaware, has been named director of the Delaware Biotechnology Institute ...

In a pine forest on Michigan’s Upper Peninsula, the only active nickel mine in the US is nearing the end of its life. At a time when carmakers want the metal for electric-vehicle batteries, nickel ...